tiprankstipranks
Outlook Therapeutics (OTLK)
NASDAQ:OTLK
US Market

Outlook Therapeutics (OTLK) Income Statement

Compare
1,363 Followers

Outlook Therapeutics Income Statement

Last quarter (Q1 2025), Outlook Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Outlook Therapeutics's net income was $17.38M. See Outlook Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ -204.69K$ -262.14K$ -554.07K
Operating Expenses
$ 71.70M$ 53.13M$ 63.07M$ 51.73M$ 36.31M
Depreciation and Amortization
$ 113.86K$ 44.19K$ 204.69K$ 262.14K$ 554.07K
EBITDA
$ -71.59M$ -56.85M$ -62.87M$ -51.46M$ -35.76M
Operating Income
$ -71.70M$ -53.13M$ -63.07M$ -51.73M$ -36.84M
Other Income/Expenses
$ -3.66M$ -4.29M$ -2.98M$ -1.43M$ -1.67M
Pretax Income
$ -75.36M$ -58.98M$ -66.05M$ -53.16M$ -38.51M
Net Income
$ -75.37M$ -58.98M$ -66.05M$ -53.16M$ -35.24M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -9.84$ -4.72$ -6.23$ -6.96$ -9.71
Diluted EPS
$ -9.76$ -4.72$ -6.23$ -6.96$ -9.71
Weighted Average Shares Outstanding
18.55M 12.51M 10.60M 7.63M 3.63M
Weighted Average Shares Outstanding (Diluted)
18.55M 12.51M 10.60M 7.63M 3.63M
Currency in USD

Outlook Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis